The efficacy and safety of topical antifungal miconazole cream in the treatment of corneal fungal infection, (Candida albicans)

Date of Publication

1995

Document Type

Bachelor's Thesis

Degree Name

Bachelor of Science in Biology

College

College of Science

Department/Unit

Biology

Abstract/Summary

Miconazole is a broad-spectrum antimycot agent that has been proven to be effective in secondary mycoses caused by Candida albicans, a fungus resembling yeast causing fungal infection in man and animals. The study determined the safety and efficacy of topical antifungal miconazole in 21 rabbits. The sample population was divided into three groups treated once, twice and thrice daily. Administration was done topically in a week with 3 hours daytime interval. Gross examination based on the percentage of adverse reactions and level of inhibation showed that once a day treatment was the safety and inhibited best the pathogenic activity of the fungus. Slow inhibition was attributed to the excessive use of miconazole observed in twice and trice daily treatment that produced edema and opacity due to hypersensitivity reaction. Finally, therapeutic safety, as measured by the spread between the effective dose and the dose at which slow adverse reactions begin to appear was significantly justified by the inhibitory performance of miconazole.

Abstract Format

html

Language

English

Format

Print

Accession Number

TU06921

Shelf Location

Archives, The Learning Commons, 12F, Henry Sy Sr. Hall

Physical Description

67 leaves

Keywords

Antifungal agents; Miconazole; Mycoses; Candida albicans; Eye--Fungi; Fungi; Pathogenic; Rabbits; Funguous diseases

This document is currently not available here.

Share

COinS